SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-003197
Filing Date
2024-01-09
Accepted
2024-01-09 08:45:19
Documents
11
Period of Report
2024-01-08
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbp-20240108.htm   iXBRL 8-K 53226
2 EX-99.1 crbp-ex99_1.htm EX-99.1 15590
  Complete submission text file 0000950170-24-003197.txt   189711

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crbp-20240108.xsd EX-101.SCH 25032
5 EXTRACTED XBRL INSTANCE DOCUMENT crbp-20240108_htm.xml XML 4767
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 24521811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)